β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.

β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.

Item
http://www.wikidata.org/entity/Q44285321
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In SilicoEffects of heat acclimation on changes in oxidative stress and inflammation caused by endurance capacity test in the heat.Association between plasma Beta-2 microglobulin level and cardiac performance in patients with chronic kidney disease.A review of the pathophysiology and potential biomarkers for peripheral artery disease.Increased arterial stiffness in patients with end-stage osteoarthritis: a case-control studyAssociation of peripheral arterial disease with all-cause and cardiovascular mortality in hemodialysis patients: a meta-analysis.High levels of serum β2-microglobulin predict severity of coronary artery diseaseIdentification of ageing-associated naturally occurring peptides in human urineUsefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.ß-2 microglobulin level is negatively associated with global left ventricular longitudinal peak systolic strain and left atrial volume index in patients with chronic kidney disease not on dialysis.A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients.Role of β2-microglobulin in uremic patients may be greater than originally suspected.Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease.Reply to arterial stiffness in patients with peripheral arterial disease.
P2860

β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients.

Item
http://www.wikidata.org/entity/Q44285321
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@en
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@nl
type
label
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@en
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@nl
prefLabel
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@en
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
β2-microglobulin, a novel biom ...... c stiffness in these patients.
@en
P2093
P2860
P304
P31
P356
10.3109/00365513.2011.558108
P433
P478
P50
P577
P5875
P698
P921